trending Market Intelligence /marketintelligence/en/news-insights/trending/3e__qub7bfi0l6a_wuqw2a2 content esgSubNav
In This List

UK's Sinclair Pharma in preliminary takeover talks with Chinese firms

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


UK's Sinclair Pharma in preliminary takeover talks with Chinese firms

U.K.'s Sinclair Pharma PLC said it received a takeover offer from China Grand Enterprises Inc. and its Huadong Medicine Co. Ltd. unit.

According to the pharmaceutical company, discussions are still at a very early stage with no certainty of an acquisition offer being made.

Under the U.K. Takeover Code, the Chinese firms are required to announce their intentions by Aug. 2.

Following news of the potential transaction, Sinclair Pharma's stock price was up 20.31% to 22 pence as of 3:48 p.m. London Time, July 5.

London-based Sinclair Pharma makes and sells dermatological products worldwide.